bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.08.08.455554

Mathematical Modeling Reveals Quantitative Properties of KEAP1-NRF2 Signaling

Abstract

In response to oxidative and electrophilic stresses, cells launch an NRF2-mediated transcriptional antioxidant program. The activation of NRF2 depends on a redox sensor, KEAP1, which acts as an E3-ligase adaptor to promote the ubiquitination and degradation of NRF2. While a great deal has been learned about this redox duo, its quantitative signaling properties are still largely unexplored. In the present study, we examined these properties including response time, half-life, maximal activation, and response steepness (ultrasensitivity) of NRF2, through mathematical modeling. The models describe, with increasing complexity, the reversible binding of KEAP1 dimer and NRF2 via the ETGE and DLG motifs, NRF2 production, KEAP1-dependent and independent NRF2 degradation, and perturbations by different classes of NRF2 activators. Our simulations revealed that at the basal condition, NRF2 molecules are largely sequestered by KEAP1, with the KEAP1-NRF2 complex distributed comparably in either an ETGE-bound only (open) state or an ETGE and DLG dual-bound (closed) state, corresponding to the unlatched and latched configurations of the conceptual hinge-latch model. With two-step ETGE binding, the open and closed states operate in cycle mode at the basal condition and transition to equilibrium mode at stressed conditions. Class I-V, electrophilic NRF2 activators, which modify redox-sensing cysteine residues of KEAP1, shift the balance to a closed state that is unable to degrade NRF2 effectively. When total NRF2 accumulates to a level that nearly saturates existing KEAP1, ultrasensitive NRF2 activation, i.e., a steep rise in the free NRF2 level, can occur. The ultrasensitivity results from two simultaneous mechanisms, zero-order degradation mediated by DLG binding and protein sequestration (molecular titration) mediated by ETGE binding. These response characteristics of class I-V activators do not require disruption of DLG binding to unlatch the KEAP1-NRF2 complex. In comparison, class VI NRF2 activators, which directly compete with NRF2 for KEAP1 binding, cause a shift to the unlatched, open state of KEAP1-NRF2 complex and ultimately its complete dissociation (unhinged), resulting in a fast release of free NRF2 followed by stabilization. Although class VI activators may induce free NRF2 to higher levels, ultrasensitivity is lost due to lower free KEAP1 and thus its NRF2-sequestering effect. Stress-induced nuclear NRF2 accumulation is enhanced when basal nuclear NRF2 turnover constitutes a small load of NRF2 production. Our simulation further demonstrated that optimal abundances of cytosolic and nuclear KEAP1 exist to maximize ultrasensitivity. In summary, by simulating the dual role of KEAP1 in repressing NRF2, i.e., sequestration and promoting degradation, our mathematical modeling provides key novel quantitative insights into the signaling properties of the KEAP1-NRF2 system, which may help with the design of novel classes of NRF2 activators and inhibitors and understanding of the toxic actions of environmental oxidative stressors.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Liu, S., Pi, J., Zhang, Q.. 2021-08-08. Mathematical Modeling Reveals Quantitative Properties of KEAP1-NRF2 Signaling. https://doi.org/10.1101/2021.08.08.455554

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology